EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemiaSara Charmsaz(QIMR Berghofer Medical Research Institute), Andy Boyd(The University of Texas at San Antonio Health Science Center)LeukemiaDecember 6, 201610.1038/leu.2016.371Cited by 38SaveCiteExport RISWatch citationsRelated PapersEphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia|PLoS ONE|2015|23